Abstract
Atherosclerotic coronary heart disease (CHD) is a major health problem worldwide. Epidemiological studies have identified the role of several modifiable and non-modifiable risk factors in the pathogenesis of CHD. Aggressive risk modification has led to a significant improvement in the morbidity and mortality from CHD. However, there is a growing need to identify better modalities of risk prediction in CHD. Many of these newer risk markers, currently under evaluation, are based on the newer concept that atherosclerosis is more than merely a problem of lipid imbalance. There has been a recent shift in the paradigm towards inflammation and oxidative stress as the key drivers in the pathophysiology of atherosclerosis and its complications. Further understanding of this complex interplay of lipid and inflammatory factors is likely to pave way to a better understanding of this disease and its myriad complications.
Keywords: Atherosclerosis, Coronary Heart Disease, Atherosclerotic coronary heart disease (CHD), lipoprotein, menopause, Hypercholesterolemia, atheroma growth, triglycerides, cardiovascular disease, dyslipidemia, hyperglycemia, atheroma, fibroatheroma, hemorrhage, thrombosis, Positron emission tomography (PET), neovascularization, photodynamic therapy (PDT)
Cardiovascular & Hematological Disorders-Drug Targets
Title: Atherosclerotic Coronary Heart Disease Epidemiology, Classification and Management
Volume: 10 Issue: 4
Author(s): Smita Negi and Aashish Anand
Affiliation:
Keywords: Atherosclerosis, Coronary Heart Disease, Atherosclerotic coronary heart disease (CHD), lipoprotein, menopause, Hypercholesterolemia, atheroma growth, triglycerides, cardiovascular disease, dyslipidemia, hyperglycemia, atheroma, fibroatheroma, hemorrhage, thrombosis, Positron emission tomography (PET), neovascularization, photodynamic therapy (PDT)
Abstract: Atherosclerotic coronary heart disease (CHD) is a major health problem worldwide. Epidemiological studies have identified the role of several modifiable and non-modifiable risk factors in the pathogenesis of CHD. Aggressive risk modification has led to a significant improvement in the morbidity and mortality from CHD. However, there is a growing need to identify better modalities of risk prediction in CHD. Many of these newer risk markers, currently under evaluation, are based on the newer concept that atherosclerosis is more than merely a problem of lipid imbalance. There has been a recent shift in the paradigm towards inflammation and oxidative stress as the key drivers in the pathophysiology of atherosclerosis and its complications. Further understanding of this complex interplay of lipid and inflammatory factors is likely to pave way to a better understanding of this disease and its myriad complications.
Export Options
About this article
Cite this article as:
Negi Smita and Anand Aashish, Atherosclerotic Coronary Heart Disease Epidemiology, Classification and Management, Cardiovascular & Hematological Disorders-Drug Targets 2010; 10 (4) . https://dx.doi.org/10.2174/187152910793743832
DOI https://dx.doi.org/10.2174/187152910793743832 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Effects of Vitamin B in Depression
Current Medicinal Chemistry Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs
CNS & Neurological Disorders - Drug Targets Barker and Brenner: A Basis for Hypertension?
Current Hypertension Reviews Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting
Infectious Disorders - Drug Targets Gender Differences in Metabolic Syndrome – A Key Research Issue
Endocrine, Metabolic & Immune Disorders - Drug Targets Foreword: The Year in Review: Comments on Plants, Cyclodextrins, Microbiota, and Diabetes
Current Pharmaceutical Design Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets
Current Topics in Medicinal Chemistry Nano-zinc Coordination with the Ligands of Carboplatin, Oxaliplatin and Nedaplatin. Synthesis, Characterization and Biological Properties
Letters in Organic Chemistry Serum Albumin Concentration and Cognitive Impairment
Current Alzheimer Research Aspirin: from a Historical Perspective
Recent Patents on Cardiovascular Drug Discovery Lipid Messengers as Targets for Antiangiogenic Therapy
Current Pharmaceutical Design From Antidepressant Drugs to Beta-Mimetics: Preclinical Insights on Potential New Treatments for Neuropathic Pain
Recent Patents on CNS Drug Discovery (Discontinued) Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update
Current Pharmaceutical Design Therapeutic Utilities of Pediatric Cardiac Catheterization
Current Cardiology Reviews Editorial [Hot Topic:Advances in Alzheimer Therapy: Understanding Pharmacological Approaches to the Disease (Guest Editors: Ana Martinez, Debomoy K. Lahiri, Ezio Giacobini and Nigel H. Greig)]
Current Alzheimer Research Update on the Pharmacological Treatment of Alzheimers Disease
Current Neuropharmacology Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Is the Deficiency of Vitamin B12 Related to Oxidative Stress and Neurotoxicity in Parkinsons Patients?
CNS & Neurological Disorders - Drug Targets Potential of Resveratrol in Preventing the Development of Heart Failure
Current Chemical Biology EDITORIAL
Pharmaceutical Nanotechnology